跳至主要内容
临床试验/CTRI/2018/06/014585
CTRI/2018/06/014585招募中1/2 期

ROLE OF DARVISEKA AND JALAUKAVCHARANA IN THE MANAGMENT OF PRAKLINNAVARTMA w.s.r TO ANTERIOR BLEPHARITIS A CLINICAL STUDY

Campus Director1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年6月1日最近更新:
适应症

试验速览

阶段
1/2 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi Seka

研究概览

简要总结

Praklinnavartma (Anterior Blepharitis) is very common Vartmagata disease (inflammation of lid) and chronic in nature its clinical features are Arujam(Painless or mild Pain), Bahay Shunama(lid sollowen lid externally), Antah klinnta(Stickyness), Shrava(Discharge), Kandu(itiching), Nistoda(Foreighn body sensation), if not treated properly trichiasis like complecations occures which causes blindness.

Patients selected in to two groups,  total 30 patients

Group A Darvi Seka Yoga in 15 patients with the duration of 15 days

Group B Jalaukavcharana in 2 sittings followed by Darvi Seka in other 15 patients in the duration of 15 days

follow up one month

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
10.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • •Patient presenting with signs and symptoms of Praklinnavartma and anterior Blepharitis.
  • •Age – 10yr-50yr.
  • •Sex – either sex.

排除标准

  • •Patient having diseases like corneal ulcer, dacryocystitis, dry eye, lagophthalmos, infective conjunctivitis etc.
  • •Patients suffering from specific eyelid disorders like ectropion, entropion, trichiasis, tumor, carcinoma, skin allergies.
  • •Systemic diseases like- DM, HTN.
  • •HIV positive patients Patient having Hb less than 10 gm%.

结局指标

主要结局

to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi Seka

时间窗: to study in detail with the prevalence etiopathogenesis clinical features complications of Praklinnavartma (Anterior Blepharitis)and its management By Darvi Seka time 15 days of therapy of Darvi Seka and Jalaukavcharana 2 sitting in 15 days therapy

次要结局

  • To evaluate clinical efficacy of jalaukavcharana followed by Seka in management of Praklinna vartma (Anterior Blepharitis)(15 Days)

研究者

发起方
Campus Director
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验